BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3137878)

  • 1. [Clinical study of combination chemotherapy using carboquone, cisplatin, UFT and OK-432 in 7 cases of advanced gastric cancers and a relapsed gastric cancer].
    Nasu K; Nakarai I; Horiuchi M; Shinoda A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2410-3. PubMed ID: 3137878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system].
    Nagamatsu Y; Nakarai I; Matsuo T; Kawahara M; Shinoda A
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3527-31. PubMed ID: 3098184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
    Sakata Y; Munakata A; Baba T; Saitoh S; Itoh T; Tamura Y; Furukohori N; Suzuki H; Kimura T; Kawata K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2065-71. PubMed ID: 3134859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].
    Furukawa H; Hara T; Taniguchi T
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1199-202. PubMed ID: 1905122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
    Aoki Y; Tabuse Y; Tanimura H; Katsumi M; Asae M; Ichimiya G; Imai T; Ooshima K; Kakihara M; Kashitani M
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):225-34. PubMed ID: 2493222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
    Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
    Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [UFT/CDDP treatment in advanced gastric cancer--case report].
    Suga S; Nagai H; Horiuchi Y; Ohkita T; Ibayashi J; Koyama Y
    Gan No Rinsho; 1989 Jan; 35(1):87-92. PubMed ID: 2493527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of relapsed pulmonary carcinoma showing an interesting chemotherapeutic course].
    Koga T; Nakarai I; Rikitake H; Shinoda A
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3355-8. PubMed ID: 3688895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
    Sakuma H; Matsuki N; Katayama K; Hirosawa H; Tomita F; Takano N; Tanaka T; Sawa T; Ueno K; Uogishi M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2557-62. PubMed ID: 2505681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
    Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
    Koda K; Nakazawa O; Morita K; Kure T; Terada S; Matsunaga T; Tsuji Y; Miyazaki E; Nakajima K; Morii K
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1893-900. PubMed ID: 2118336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Tsuji A; Shima Y; Morita S; Uchida M; Okamoto K; Morita M; Horimi T; Shirasaka T
    Anticancer Res; 2008; 28(2B):1433-8. PubMed ID: 18505092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.